iShares Core S&P Small-Cap ETF (IJR)

For 2026, the company's guidance reflected sales that assume a measured consumer environment.

JPMorgan analyst Bryan Smilek assigned a ‘Neutral’ rating with a $50 price target.

Last week, Telsey Advisory lowered the price target to $55 from $65 with a Market Perform rating following the company’s disappointing holiday sales and Q4 guidance

The company said it intends to complete the share purchase in connection with its existing authorization of 68.5 million shares.

The appetite for risk has taken a hit in recent weeks, although the worst of the selling has, so far, been contained to US stocks, on a year-to-date basis.

Kohl’s posted better-than-expected earnings, with earnings per share of $0.95, surpassing estimates of $0.72.

Wall Street analysts expect the company to post Q4 earnings per share of $3.52 on revenue of $3.78 billion.

The company cited an "uncertain" macro environment, a shift in consumer confidence, and headwinds from unseasonal weather in the U.S.

CEO Adam Grossman highlighted a 65% year-over-year jump in total revenue and a staggering 309% increase in adjusted EBITDA for 2024.

Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.

Citi upgraded Bath & Body Works from ‘Neutral’ to ‘Buy’ following the company’s post-earnings share sell-off

cars-com-stock-snags-another-price-target-cut

The revenue miss was due to a slowdown in spending from existing customers that began in October and one of the company’s largest customers pulling back its business significantly.

Sentiment on Stocktwits remained ‘neutral’ compared to a week ago

Its first quarter 2025 earnings per diluted share is expected to be between $0.36 and $0.43, compared to the consensus estimate of $0.44.

Sentiment on Stocktwits turned ‘bearish’ compared to ‘bullish’ a week ago

Segment-wise, revenue at ‘Topgolf’remained flat at $439.0 million

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

Shake Shack’s Q4 saw “broad-based strength across the business”

Brand Tripadvisor accounted for roughly half of the total revenue but witnessed a 6% revenue drop.

Leslie’s recently reported mixed first-quarter results.

Etsy expects its consolidated first quarter 2025 GMS will decline at a rate similar to the year-over-year performance reported for the fourth quarter

One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.

A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.